Improving compliance with helicobacter pylori eradication therapy: when and how? (Q34409052)

2 August 2017

1 reference

title

Improving compliance with helicobacter pylori eradication therapy: when and how? (English)

1 reference

Helicobacter pylori infectious disease

2 August 2017

0 references

1 reference

inferred from title

author name string

John P Anthony O'Connor

series ordinal

1

1 reference

PubMed ID

21180555

2 August 2017

Ikue Taneike

series ordinal

2

1 reference

PubMed ID

21180555

2 August 2017

Colm O'Morain

series ordinal

3

1 reference

2 August 2017

1 September 2009

1 reference

Therapeutic Advances in Gastroenterology

2 August 2017

1 reference

2 August 2017

2

1 reference

2 August 2017

5

1 reference

2 August 2017

273-279

1 reference

Impact of fixed-dose combination drugs on adherence to prescription medications

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Public awareness of risk factors for cancer among the Japanese general population: a population-based survey

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

H pylori antibiotic resistance: prevalence, importance, and advances in testing

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Fluoroquinolones and risk of Achilles tendon disorders: case-control study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Management of Helicobacter pylori eradication--the influence of structured counselling and follow-up

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Beyond "compliance" is "adherence". Improving the prospect of diabetes care

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Factors influencing the eradication of Helicobacter pylori with triple therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002536

Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.

6 July 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X09337342

New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X09337342

Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X09337342

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X09337342

The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X09337342

Survey of the opinions, knowledge and practices of surgeons and internists regarding Helicobacter pylori test-and-treat policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X09337342

Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X09337342

Cure of Helicobacter pylori infection in all compliant patients: report on 644 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X09337342

Acute fatal hepatitis related to levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756283X09337342

Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: the HelP Study

21 January 2018

1 reference

12 December 2020

Treatment of Helicobacter pylori infection in clinical practice in the United States: results from 224 patients

1 reference

12 December 2020

Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology

1 reference

12 December 2020

Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes

1 reference

12 December 2020

A survey of internal medicine residents' knowledge about Helicobacter pylori infection

1 reference

12 December 2020

Levofloxacin in first-line treatment of Helicobacter pylori infection

1 reference

12 December 2020

Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994

1 reference

12 December 2020

Practice patterns for managing Helicobacter pylori infection and upper gastrointestinal symptoms

1 reference

12 December 2020

Compliance with drug therapy-new answers to an old question

1 reference

12 December 2020

Identifiers

DOI

10.1177/1756283X09337342

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

PubMed ID

21180555